Global Markets
S&P 500 — US Large Cap Index
NASDAQ 100 — Tech Growth Index
Dow Jones — Industrial Average
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico Market
S&P 500 — US Large Cap Index
NASDAQ 100 — Tech Growth Index
Dow Jones — Industrial Average
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico Market
AED • EUR • GBP • USD IBANs   |   CROSS BORDER FX   |   LOCAL CURRENCIES   |   GLOBAL COVERAGE
Indices

ASX 200 Up 0.7% at Close

Australia’s ASX 200 rose 59 points, or 0.7%, to end at 8,823 on Monday, building strength from the prior session amid a sharp rise in U.S. stock futures as Washington and Tehran reportedly agreed to halt hostilities and resume peace talks. Sentiment was also lifted by strong growth in China’s industrial profits over the first five months of 2026, highlighting resilience in Australia’s key trading partner. However, caution emerged ahead of China’s June PMI data later this week, both from officials and a private survey. Meanwhile, the Reserve Bank’s June minutes will also be due, with investors wary that the central bank may retain its tightening bias to rein in inflation. Commercial services, consumer non-durables, and healthcare drove the gains. Strong iron ore prices supported BHP Group (1.4%) and Fortescue (2.4%). Ramelius Resources climbed 2.3% after agreeing to sell its Edna May Gold Hub. Neuren Pharmaceuticals surged 36.1% on EU approval for its Rett syndrome drug.

Register a Revolut Business Account
```

Market Analysis & Disclaimer

The market information, analysis, commentary, forecasts and opinions contained in this publication are provided by Octalas Group Ltd on behalf of Today Markets and Currency Hedger using information and data obtained from sources believed to be reliable. However, Octalas Group Ltd, Today Markets and Currency Hedger do not warrant or guarantee the accuracy, completeness or timeliness of the information presented and accept no responsibility for any loss or damage arising from reliance upon information contained herein, to the extent permitted by applicable law.

Market forecasts, expectations and opinions are based on analysis of available information and a number of assumptions regarding economic, financial, political and market conditions. Such assumptions may prove to be incorrect, and actual market developments may differ materially from those described or anticipated.

Nothing contained in this publication constitutes investment advice, financial advice, a personal recommendation, an offer, solicitation or invitation to buy, sell or otherwise transact in any financial instrument or investment product. The information is provided for general informational and educational purposes only and does not take into account the investment objectives, financial situation, experience or particular circumstances of any individual reader.

Past performance is not indicative of future results. Financial markets, including foreign exchange, commodities, equities, derivatives and other financial instruments, involve risk and prices can move rapidly. Readers should conduct their own independent research and, where appropriate, obtain advice from an appropriately authorised financial professional before making any investment or trading decision.

Where this publication refers to Today Markets, it represents market news, research, analysis and commentary published for informational purposes. Where Currency Hedger is referenced, it represents commentary concerning foreign exchange, currency exposure, international payments and hedging-related topics. References to particular financial instruments, markets, companies, currencies or commodities should not be interpreted as a recommendation to transact in them.

Octalas Group Ltd, Today Markets and Currency Hedger may have commercial interests or relationships with businesses, financial-service providers, technology providers or other market participants mentioned in their publications. Where relevant, such relationships or interests may create potential conflicts of interest. Appropriate measures are intended to be taken to ensure that published analysis and commentary are presented objectively and that commercial considerations do not determine the substance of market analysis.

The views expressed in this publication are those of the author or contributors at the time of publication and may change without notice as market conditions develop. Readers should not assume that any information contained herein has been updated following publication.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button